APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chickenpox (Varicella) Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Chickenpox (Varicella) Vaccine Market Analysis and Forecast 2026-2032

21 December 2025190 pages

Choose your research edition.

Industry ResearchChickenpox (Varicella) Vaccine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Chickenpox (Varicella) Vaccine Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Chickenpox (Varicella) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chickenpox (Varicella) Vaccine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Chickenpox (Varicella) Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Chickenpox (Varicella) Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Chickenpox (Varicella) Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Chickenpox (Varicella) Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Chickenpox (Varicella) Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Chickenpox (Varicella) Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Chickenpox (Varicella) Vaccine include Shanghai Institute, Merck & Co., GSK, Sanofi Pasteur, Keygen, Green Cross, Changsheng, Biken and BCHT, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Chickenpox (Varicella) Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Chickenpox (Varicella) Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Chickenpox (Varicella) Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Chickenpox (Varicella) Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Chickenpox (Varicella) Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Chickenpox (Varicella) Vaccine sales, projected growth trends, production technology, application and end-user industry.

Chickenpox (Varicella) Vaccine Segment by Company

Shanghai Institute

Merck & Co.

GSK

Sanofi Pasteur

Keygen

Green Cross

Changsheng

Biken

BCHT

Chickenpox (Varicella) Vaccine Segment by Type

Monovalent Vaccine

Combination Vaccine

Chickenpox (Varicella) Vaccine Segment by Application

Kids Injection

Adults Injection

Chickenpox (Varicella) Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chickenpox (Varicella) Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chickenpox (Varicella) Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chickenpox (Varicella) Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Chickenpox (Varicella) Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Chickenpox (Varicella) Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chickenpox (Varicella) Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Chickenpox (Varicella) Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Monovalent Vaccine Major Manufacturers Table 3. Combination Vaccine Major Manufacturers Table 4. Global Chickenpox (Varicella) Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Kids Injection Major Manufacturers Table 6. Adults Injection Major Manufacturers Table 7. Chickenpox (Varicella) Vaccine Industry Trends Table 8. Chickenpox (Varicella) Vaccine Industry Drivers Table 9. Chickenpox (Varicella) Vaccine Industry Opportunities and Challenges Table 10. Chickenpox (Varicella) Vaccine Industry Restraints Table 11. Global Chickenpox (Varicella) Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Chickenpox (Varicella) Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Chickenpox (Varicella) Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global Chickenpox (Varicella) Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Chickenpox (Varicella) Vaccine Sales by Region (2021-2026) & (k units) Table 18. Global Chickenpox (Varicella) Vaccine Sales by Region (2027-2032) & (k units) Table 19. Global Chickenpox (Varicella) Vaccine Sales Market Share by Region (2021-2026) Table 20. Global Chickenpox (Varicella) Vaccine Sales Market Share by Region (2027-2032) Table 21. Global Chickenpox (Varicella) Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Chickenpox (Varicella) Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Chickenpox (Varicella) Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Chickenpox (Varicella) Vaccine Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Chickenpox (Varicella) Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Chickenpox (Varicella) Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Chickenpox (Varicella) Vaccine Manufacturers, Product Type & Application Table 29. Global Chickenpox (Varicella) Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Chickenpox (Varicella) Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Chickenpox (Varicella) Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Chickenpox (Varicella) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Chickenpox (Varicella) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global Chickenpox (Varicella) Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (k units) Table 39. Global Chickenpox (Varicella) Vaccine Sales by Type (2027-2032) & (k units) Table 40. Global Chickenpox (Varicella) Vaccine Sales Market Share by Type (2021-2026) Table 41. Global Chickenpox (Varicella) Vaccine Sales Market Share by Type (2027-2032) Table 42. Global Chickenpox (Varicella) Vaccine Price by Type (2021-2026) & (US$/unit) Table 43. Global Chickenpox (Varicella) Vaccine Price by Type (2027-2032) & (US$/unit) Table 44. Global Chickenpox (Varicella) Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Chickenpox (Varicella) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Chickenpox (Varicella) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global Chickenpox (Varicella) Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (k units) Table 51. Global Chickenpox (Varicella) Vaccine Sales by Application (2027-2032) & (k units) Table 52. Global Chickenpox (Varicella) Vaccine Sales Market Share by Application (2021-2026) Table 53. Global Chickenpox (Varicella) Vaccine Sales Market Share by Application (2027-2032) Table 54. Global Chickenpox (Varicella) Vaccine Price by Application (2021-2026) & (US$/unit) Table 55. Global Chickenpox (Varicella) Vaccine Price by Application (2027-2032) & (US$/unit) Table 56. Shanghai Institute Company Information Table 57. Shanghai Institute Business Overview Table 58. Shanghai Institute Chickenpox (Varicella) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Shanghai Institute Chickenpox (Varicella) Vaccine Product Portfolio Table 60. Shanghai Institute Recent Development Table 61. Merck & Co. Company Information Table 62. Merck & Co. Business Overview Table 63. Merck & Co. Chickenpox (Varicella) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Merck & Co. Chickenpox (Varicella) Vaccine Product Portfolio Table 65. Merck & Co. Recent Development Table 66. GSK Company Information Table 67. GSK Business Overview Table 68. GSK Chickenpox (Varicella) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. GSK Chickenpox (Varicella) Vaccine Product Portfolio Table 70. GSK Recent Development Table 71. Sanofi Pasteur Company Information Table 72. Sanofi Pasteur Business Overview Table 73. Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Sanofi Pasteur Chickenpox (Varicella) Vaccine Product Portfolio Table 75. Sanofi Pasteur Recent Development Table 76. Keygen Company Information Table 77. Keygen Business Overview Table 78. Keygen Chickenpox (Varicella) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Keygen Chickenpox (Varicella) Vaccine Product Portfolio Table 80. Keygen Recent Development Table 81. Green Cross Company Information Table 82. Green Cross Business Overview Table 83. Green Cross Chickenpox (Varicella) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Green Cross Chickenpox (Varicella) Vaccine Product Portfolio Table 85. Green Cross Recent Development Table 86. Changsheng Company Information Table 87. Changsheng Business Overview Table 88. Changsheng Chickenpox (Varicella) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Changsheng Chickenpox (Varicella) Vaccine Product Portfolio Table 90. Changsheng Recent Development Table 91. Biken Company Information Table 92. Biken Business Overview Table 93. Biken Chickenpox (Varicella) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Biken Chickenpox (Varicella) Vaccine Product Portfolio Table 95. Biken Recent Development Table 96. BCHT Company Information Table 97. BCHT Business Overview Table 98. BCHT Chickenpox (Varicella) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. BCHT Chickenpox (Varicella) Vaccine Product Portfolio Table 100. BCHT Recent Development Table 101. North America Chickenpox (Varicella) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Chickenpox (Varicella) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (k units) Table 104. North America Chickenpox (Varicella) Vaccine Sales by Type (2027-2032) & (k units) Table 105. North America Chickenpox (Varicella) Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 106. North America Chickenpox (Varicella) Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 107. North America Chickenpox (Varicella) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 108. North America Chickenpox (Varicella) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 109. North America Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (k units) Table 110. North America Chickenpox (Varicella) Vaccine Sales by Application (2027-2032) & (k units) Table 111. North America Chickenpox (Varicella) Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 112. North America Chickenpox (Varicella) Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 113. North America Chickenpox (Varicella) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Chickenpox (Varicella) Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 115. North America Chickenpox (Varicella) Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 116. North America Chickenpox (Varicella) Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 117. North America Chickenpox (Varicella) Vaccine Sales by Country (2021-2026) & (k units) Table 118. North America Chickenpox (Varicella) Vaccine Sales by Country (2027-2032) & (k units) Table 119. North America Chickenpox (Varicella) Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 120. North America Chickenpox (Varicella) Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 121. United States Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 122. Canada Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 123. Mexico Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 124. Europe Chickenpox (Varicella) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Chickenpox (Varicella) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (k units) Table 127. Europe Chickenpox (Varicella) Vaccine Sales by Type (2027-2032) & (k units) Table 128. Europe Chickenpox (Varicella) Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 129. Europe Chickenpox (Varicella) Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 130. Europe Chickenpox (Varicella) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe Chickenpox (Varicella) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (k units) Table 133. Europe Chickenpox (Varicella) Vaccine Sales by Application (2027-2032) & (k units) Table 134. Europe Chickenpox (Varicella) Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 135. Europe Chickenpox (Varicella) Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 136. Europe Chickenpox (Varicella) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Chickenpox (Varicella) Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. Europe Chickenpox (Varicella) Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. Europe Chickenpox (Varicella) Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 140. Europe Chickenpox (Varicella) Vaccine Sales by Country (2021-2026) & (k units) Table 141. Europe Chickenpox (Varicella) Vaccine Sales by Country (2027-2032) & (k units) Table 142. Europe Chickenpox (Varicella) Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 143. Europe Chickenpox (Varicella) Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 144. Germany Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 145. France Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 146. U.K. Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 147. Italy Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 148. Russia Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 149. Spain Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 150. Netherlands Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 151. Switzerland Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 152. Sweden Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 153. Poland Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 154. China Chickenpox (Varicella) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 155. China Chickenpox (Varicella) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 156. China Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (k units) Table 157. China Chickenpox (Varicella) Vaccine Sales by Type (2027-2032) & (k units) Table 158. China Chickenpox (Varicella) Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 159. China Chickenpox (Varicella) Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 160. China Chickenpox (Varicella) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 161. China Chickenpox (Varicella) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 162. China Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (k units) Table 163. China Chickenpox (Varicella) Vaccine Sales by Application (2027-2032) & (k units) Table 164. China Chickenpox (Varicella) Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 165. China Chickenpox (Varicella) Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 166. Asia Chickenpox (Varicella) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 167. Asia Chickenpox (Varicella) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 168. Asia Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (k units) Table 169. Asia Chickenpox (Varicella) Vaccine Sales by Type (2027-2032) & (k units) Table 170. Asia Chickenpox (Varicella) Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 171. Asia Chickenpox (Varicella) Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 172. Asia Chickenpox (Varicella) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 173. Asia Chickenpox (Varicella) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 174. Asia Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (k units) Table 175. Asia Chickenpox (Varicella) Vaccine Sales by Application (2027-2032) & (k units) Table 176. Asia Chickenpox (Varicella) Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 177. Asia Chickenpox (Varicella) Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 178. Asia Chickenpox (Varicella) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Asia Chickenpox (Varicella) Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. Asia Chickenpox (Varicella) Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. Asia Chickenpox (Varicella) Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 182. Asia Chickenpox (Varicella) Vaccine Sales by Country (2021-2026) & (k units) Table 183. Asia Chickenpox (Varicella) Vaccine Sales by Country (2027-2032) & (k units) Table 184. Asia Chickenpox (Varicella) Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 185. Asia Chickenpox (Varicella) Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 186. Japan Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 187. South Korea Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 188. India Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 189. Australia Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 190. Taiwan Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 191. Southeast Asia Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 192. SAMEA Chickenpox (Varicella) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 193. SAMEA Chickenpox (Varicella) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 194. SAMEA Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (k units) Table 195. SAMEA Chickenpox (Varicella) Vaccine Sales by Type (2027-2032) & (k units) Table 196. SAMEA Chickenpox (Varicella) Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 197. SAMEA Chickenpox (Varicella) Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 198. SAMEA Chickenpox (Varicella) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 199. SAMEA Chickenpox (Varicella) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 200. SAMEA Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (k units) Table 201. SAMEA Chickenpox (Varicella) Vaccine Sales by Application (2027-2032) & (k units) Table 202. SAMEA Chickenpox (Varicella) Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 203. SAMEA Chickenpox (Varicella) Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 204. SAMEA Chickenpox (Varicella) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. SAMEA Chickenpox (Varicella) Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. SAMEA Chickenpox (Varicella) Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. SAMEA Chickenpox (Varicella) Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 208. SAMEA Chickenpox (Varicella) Vaccine Sales by Country (2021-2026) & (k units) Table 209. SAMEA Chickenpox (Varicella) Vaccine Sales by Country (2027-2032) & (k units) Table 210. SAMEA Chickenpox (Varicella) Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 211. SAMEA Chickenpox (Varicella) Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 212. Brazil Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 213. Argentina Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 214. Chile Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 215. Colombia Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 216. Peru Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 217. Saudi Arabia Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 218. Israel Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 219. UAE Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 220. Turkey Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 221. Iran Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 222. Egypt Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Table 223. Key Raw Materials Table 224. Raw Materials Key Suppliers Table 225. Chickenpox (Varicella) Vaccine Distributors List Table 226. Chickenpox (Varicella) Vaccine Customers List Table 227. Research Programs/Design for This Report Table 228. Authors List of This Report Table 229. Secondary Sources Table 230. Primary Sources List of Figures Figure 1. Chickenpox (Varicella) Vaccine Image Figure 2. Global Chickenpox (Varicella) Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chickenpox (Varicella) Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Monovalent Vaccine Image Figure 5. Combination Vaccine Image Figure 6. Global Chickenpox (Varicella) Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Chickenpox (Varicella) Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Kids Injection Image Figure 9. Adults Injection Image Figure 10. Global Chickenpox (Varicella) Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global Chickenpox (Varicella) Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global Chickenpox (Varicella) Vaccine Sales (2021-2032) & (k units) Figure 16. Global Chickenpox (Varicella) Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Chickenpox (Varicella) Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Chickenpox (Varicella) Vaccine Sales YoY (2021-2032) & (k units) Figure 19. Europe Chickenpox (Varicella) Vaccine Sales YoY (2021-2032) & (k units) Figure 20. China Chickenpox (Varicella) Vaccine Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Chickenpox (Varicella) Vaccine Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Chickenpox (Varicella) Vaccine Sales YoY (2021-2032) & (k units) Figure 23. Global Chickenpox (Varicella) Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Chickenpox (Varicella) Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Chickenpox (Varicella) Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global Chickenpox (Varicella) Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Chickenpox (Varicella) Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Chickenpox (Varicella) Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global Chickenpox (Varicella) Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Application (2021-2032) Figure 35. Global Chickenpox (Varicella) Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Chickenpox (Varicella) Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Chickenpox (Varicella) Vaccine Sales Market Share by Application (2021-2032) Figure 38. North America Chickenpox (Varicella) Vaccine Revenue Share by Type (2021-2032) Figure 39. North America Chickenpox (Varicella) Vaccine Sales Share by Type (2021-2032) Figure 40. North America Chickenpox (Varicella) Vaccine Revenue Share by Application (2021-2032) Figure 41. North America Chickenpox (Varicella) Vaccine Sales Share by Application (2021-2032) Figure 42. North America Chickenpox (Varicella) Vaccine Revenue Share by Country (2021-2032) Figure 43. North America Chickenpox (Varicella) Vaccine Sales Share by Country (2021-2032) Figure 44. Europe Chickenpox (Varicella) Vaccine Revenue Share by Type (2021-2032) Figure 45. Europe Chickenpox (Varicella) Vaccine Sales Share by Type (2021-2032) Figure 46. Europe Chickenpox (Varicella) Vaccine Revenue Share by Application (2021-2032) Figure 47. Europe Chickenpox (Varicella) Vaccine Sales Share by Application (2021-2032) Figure 48. Europe Chickenpox (Varicella) Vaccine Revenue Share by Country (2021-2032) Figure 49. Europe Chickenpox (Varicella) Vaccine Sales Share by Country (2021-2032) Figure 50. China Chickenpox (Varicella) Vaccine Revenue Share by Type (2021-2032) Figure 51. China Chickenpox (Varicella) Vaccine Sales Share by Type (2021-2032) Figure 52. China Chickenpox (Varicella) Vaccine Revenue Share by Application (2021-2032) Figure 53. China Chickenpox (Varicella) Vaccine Sales Share by Application (2021-2032) Figure 54. Asia Chickenpox (Varicella) Vaccine Revenue Share by Type (2021-2032) Figure 55. Asia Chickenpox (Varicella) Vaccine Sales Share by Type (2021-2032) Figure 56. Asia Chickenpox (Varicella) Vaccine Revenue Share by Application (2021-2032) Figure 57. Asia Chickenpox (Varicella) Vaccine Sales Share by Application (2021-2032) Figure 58. Asia Chickenpox (Varicella) Vaccine Revenue Share by Country (2021-2032) Figure 59. Asia Chickenpox (Varicella) Vaccine Sales Share by Country (2021-2032) Figure 60. SAMEA Chickenpox (Varicella) Vaccine Revenue Share by Type (2021-2032) Figure 61. SAMEA Chickenpox (Varicella) Vaccine Sales Share by Type (2021-2032) Figure 62. SAMEA Chickenpox (Varicella) Vaccine Revenue Share by Application (2021-2032) Figure 63. SAMEA Chickenpox (Varicella) Vaccine Sales Share by Application (2021-2032) Figure 64. SAMEA Chickenpox (Varicella) Vaccine Revenue Share by Country (2021-2032) Figure 65. SAMEA Chickenpox (Varicella) Vaccine Sales Share by Country (2021-2032) Figure 66. Chickenpox (Varicella) Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Chickenpox (Varicella) Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Monovalent Vaccine
  • Combination Vaccine
Applications
  • Kids Injection
  • Adults Injection
Companies covered
  • Shanghai Institute
  • Merck & Co.
  • GSK
  • Sanofi Pasteur
  • Keygen
  • Green Cross
  • Changsheng
  • Biken
  • BCHT

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Chickenpox (Varicella) Vaccine Market by Type
  3. 1.2.1 Global Chickenpox (Varicella) Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Monovalent Vaccine
  5. 1.2.3 Combination Vaccine
  6. 1.3 Chickenpox (Varicella) Vaccine Market by Application
  7. 1.3.1 Global Chickenpox (Varicella) Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Kids Injection
  9. 1.3.3 Adults Injection
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Chickenpox (Varicella) Vaccine Market Dynamics
  1. 2.1 Chickenpox (Varicella) Vaccine Industry Trends
  2. 2.2 Chickenpox (Varicella) Vaccine Industry Drivers
  3. 2.3 Chickenpox (Varicella) Vaccine Industry Opportunities and Challenges
  4. 2.4 Chickenpox (Varicella) Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Chickenpox (Varicella) Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Chickenpox (Varicella) Vaccine Revenue by Region
  3. 3.2.1 Global Chickenpox (Varicella) Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Chickenpox (Varicella) Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Chickenpox (Varicella) Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Chickenpox (Varicella) Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Chickenpox (Varicella) Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Chickenpox (Varicella) Vaccine Sales by Region
  9. 3.4.1 Global Chickenpox (Varicella) Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Chickenpox (Varicella) Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Chickenpox (Varicella) Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Chickenpox (Varicella) Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Chickenpox (Varicella) Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Chickenpox (Varicella) Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Chickenpox (Varicella) Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Chickenpox (Varicella) Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Chickenpox (Varicella) Vaccine Sales by Manufacturers
  6. 4.2.1 Global Chickenpox (Varicella) Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Chickenpox (Varicella) Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Chickenpox (Varicella) Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Chickenpox (Varicella) Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Chickenpox (Varicella) Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Chickenpox (Varicella) Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Chickenpox (Varicella) Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Chickenpox (Varicella) Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Chickenpox (Varicella) Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Chickenpox (Varicella) Vaccine Tier 1, Tier 2, and Tier 3
5 Chickenpox (Varicella) Vaccine Market by Type
  1. 5.1 Global Chickenpox (Varicella) Vaccine Revenue by Type
  2. 5.1.1 Global Chickenpox (Varicella) Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Chickenpox (Varicella) Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Chickenpox (Varicella) Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Chickenpox (Varicella) Vaccine Sales by Type
  6. 5.2.1 Global Chickenpox (Varicella) Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Chickenpox (Varicella) Vaccine Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Chickenpox (Varicella) Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Chickenpox (Varicella) Vaccine Price by Type
6 Chickenpox (Varicella) Vaccine Market by Application
  1. 6.1 Global Chickenpox (Varicella) Vaccine Revenue by Application
  2. 6.1.1 Global Chickenpox (Varicella) Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Chickenpox (Varicella) Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Chickenpox (Varicella) Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Chickenpox (Varicella) Vaccine Sales by Application
  6. 6.2.1 Global Chickenpox (Varicella) Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Chickenpox (Varicella) Vaccine Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Chickenpox (Varicella) Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Chickenpox (Varicella) Vaccine Price by Application
7 Company Profiles
  1. 7.1 Shanghai Institute
  2. 7.1.1 Shanghai Institute Company Information
  3. 7.1.2 Shanghai Institute Business Overview
  4. 7.1.3 Shanghai Institute Chickenpox (Varicella) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Shanghai Institute Chickenpox (Varicella) Vaccine Product Portfolio
  6. 7.1.5 Shanghai Institute Recent Developments
  7. 7.2 Merck & Co.
  8. 7.2.1 Merck & Co. Company Information
  9. 7.2.2 Merck & Co. Business Overview
  10. 7.2.3 Merck & Co. Chickenpox (Varicella) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck & Co. Chickenpox (Varicella) Vaccine Product Portfolio
  12. 7.2.5 Merck & Co. Recent Developments
  13. 7.3 GSK
  14. 7.3.1 GSK Company Information
  15. 7.3.2 GSK Business Overview
  16. 7.3.3 GSK Chickenpox (Varicella) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 GSK Chickenpox (Varicella) Vaccine Product Portfolio
  18. 7.3.5 GSK Recent Developments
  19. 7.4 Sanofi Pasteur
  20. 7.4.1 Sanofi Pasteur Company Information
  21. 7.4.2 Sanofi Pasteur Business Overview
  22. 7.4.3 Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sanofi Pasteur Chickenpox (Varicella) Vaccine Product Portfolio
  24. 7.4.5 Sanofi Pasteur Recent Developments
  25. 7.5 Keygen
  26. 7.5.1 Keygen Company Information
  27. 7.5.2 Keygen Business Overview
  28. 7.5.3 Keygen Chickenpox (Varicella) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Keygen Chickenpox (Varicella) Vaccine Product Portfolio
  30. 7.5.5 Keygen Recent Developments
  31. 7.6 Green Cross
  32. 7.6.1 Green Cross Company Information
  33. 7.6.2 Green Cross Business Overview
  34. 7.6.3 Green Cross Chickenpox (Varicella) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Green Cross Chickenpox (Varicella) Vaccine Product Portfolio
  36. 7.6.5 Green Cross Recent Developments
  37. 7.7 Changsheng
  38. 7.7.1 Changsheng Company Information
  39. 7.7.2 Changsheng Business Overview
  40. 7.7.3 Changsheng Chickenpox (Varicella) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Changsheng Chickenpox (Varicella) Vaccine Product Portfolio
  42. 7.7.5 Changsheng Recent Developments
  43. 7.8 Biken
  44. 7.8.1 Biken Company Information
  45. 7.8.2 Biken Business Overview
  46. 7.8.3 Biken Chickenpox (Varicella) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Biken Chickenpox (Varicella) Vaccine Product Portfolio
  48. 7.8.5 Biken Recent Developments
  49. 7.9 BCHT
  50. 7.9.1 BCHT Company Information
  51. 7.9.2 BCHT Business Overview
  52. 7.9.3 BCHT Chickenpox (Varicella) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 BCHT Chickenpox (Varicella) Vaccine Product Portfolio
  54. 7.9.5 BCHT Recent Developments
8 North America
  1. 8.1 North America Chickenpox (Varicella) Vaccine Market Size by Type
  2. 8.1.1 North America Chickenpox (Varicella) Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Chickenpox (Varicella) Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Chickenpox (Varicella) Vaccine Price by Type (2021-2032)
  5. 8.2 North America Chickenpox (Varicella) Vaccine Market Size by Application
  6. 8.2.1 North America Chickenpox (Varicella) Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Chickenpox (Varicella) Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Chickenpox (Varicella) Vaccine Price by Application (2021-2032)
  9. 8.3 North America Chickenpox (Varicella) Vaccine Market Size by Country
  10. 8.3.1 North America Chickenpox (Varicella) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Chickenpox (Varicella) Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Chickenpox (Varicella) Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Chickenpox (Varicella) Vaccine Market Size by Type
  2. 9.1.1 Europe Chickenpox (Varicella) Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Chickenpox (Varicella) Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Chickenpox (Varicella) Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Chickenpox (Varicella) Vaccine Market Size by Application
  6. 9.2.1 Europe Chickenpox (Varicella) Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Chickenpox (Varicella) Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Chickenpox (Varicella) Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Chickenpox (Varicella) Vaccine Market Size by Country
  10. 9.3.1 Europe Chickenpox (Varicella) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Chickenpox (Varicella) Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Chickenpox (Varicella) Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Chickenpox (Varicella) Vaccine Market Size by Type
  2. 10.1.1 China Chickenpox (Varicella) Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Chickenpox (Varicella) Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Chickenpox (Varicella) Vaccine Price by Type (2021-2032)
  5. 10.2 China Chickenpox (Varicella) Vaccine Market Size by Application
  6. 10.2.1 China Chickenpox (Varicella) Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Chickenpox (Varicella) Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Chickenpox (Varicella) Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Chickenpox (Varicella) Vaccine Market Size by Type
  2. 11.1.1 Asia Chickenpox (Varicella) Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Chickenpox (Varicella) Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Chickenpox (Varicella) Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Chickenpox (Varicella) Vaccine Market Size by Application
  6. 11.2.1 Asia Chickenpox (Varicella) Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Chickenpox (Varicella) Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Chickenpox (Varicella) Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Chickenpox (Varicella) Vaccine Market Size by Country
  10. 11.3.1 Asia Chickenpox (Varicella) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Chickenpox (Varicella) Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Chickenpox (Varicella) Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Chickenpox (Varicella) Vaccine Market Size by Type
  2. 12.1.1 SAMEA Chickenpox (Varicella) Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Chickenpox (Varicella) Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Chickenpox (Varicella) Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Chickenpox (Varicella) Vaccine Market Size by Application
  6. 12.2.1 SAMEA Chickenpox (Varicella) Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Chickenpox (Varicella) Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Chickenpox (Varicella) Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Chickenpox (Varicella) Vaccine Market Size by Country
  10. 12.3.1 SAMEA Chickenpox (Varicella) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Chickenpox (Varicella) Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Chickenpox (Varicella) Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Chickenpox (Varicella) Vaccine Value Chain Analysis
  2. 13.1.1 Chickenpox (Varicella) Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Chickenpox (Varicella) Vaccine Production Mode & Process
  6. 13.2 Chickenpox (Varicella) Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Chickenpox (Varicella) Vaccine Distributors
  9. 13.2.3 Chickenpox (Varicella) Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst